Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cocaine | 70 | 2015 | 1007 | 6.010 |
Why?
|
Saimiri | 92 | 2019 | 330 | 2.640 |
Why?
|
Cocaine-Related Disorders | 16 | 2015 | 460 | 2.640 |
Why?
|
Self Administration | 37 | 2019 | 385 | 2.580 |
Why?
|
Behavior, Animal | 46 | 2010 | 1881 | 2.280 |
Why?
|
Dopamine Agonists | 18 | 2009 | 355 | 1.980 |
Why?
|
Narcotics | 11 | 2009 | 343 | 1.810 |
Why?
|
Discrimination Learning | 22 | 2010 | 280 | 1.760 |
Why?
|
Conditioning, Operant | 30 | 2015 | 313 | 1.750 |
Why?
|
Receptors, Dopamine D2 | 13 | 2010 | 475 | 1.570 |
Why?
|
Heroin | 9 | 2009 | 117 | 1.570 |
Why?
|
Dopamine Uptake Inhibitors | 18 | 2015 | 312 | 1.510 |
Why?
|
Receptors, Dopamine D1 | 13 | 2010 | 291 | 1.480 |
Why?
|
Behavior, Addictive | 9 | 2019 | 462 | 1.420 |
Why?
|
Reinforcement Schedule | 28 | 2011 | 129 | 1.350 |
Why?
|
Receptors, Opioid, mu | 7 | 2019 | 182 | 0.940 |
Why?
|
Receptors, Metabotropic Glutamate | 4 | 2012 | 211 | 0.910 |
Why?
|
Dose-Response Relationship, Drug | 57 | 2019 | 10943 | 0.770 |
Why?
|
Receptors, Dopamine | 8 | 2008 | 295 | 0.730 |
Why?
|
Dopamine Antagonists | 10 | 2004 | 296 | 0.720 |
Why?
|
Extinction, Psychological | 8 | 2015 | 376 | 0.720 |
Why?
|
Receptors, Dopamine D3 | 3 | 2010 | 110 | 0.710 |
Why?
|
Naltrexone | 8 | 2009 | 307 | 0.660 |
Why?
|
Anti-Anxiety Agents | 9 | 2002 | 390 | 0.630 |
Why?
|
Norepinephrine | 4 | 2010 | 909 | 0.620 |
Why?
|
Receptors, Opioid | 5 | 2007 | 155 | 0.600 |
Why?
|
Triazolam | 5 | 2002 | 16 | 0.570 |
Why?
|
Glycine Plasma Membrane Transport Proteins | 2 | 2012 | 21 | 0.540 |
Why?
|
GABA Agonists | 6 | 2005 | 111 | 0.500 |
Why?
|
Piperazines | 15 | 2009 | 2488 | 0.500 |
Why?
|
Excitatory Amino Acid Antagonists | 3 | 2008 | 449 | 0.490 |
Why?
|
Injections, Intravenous | 15 | 2009 | 1420 | 0.480 |
Why?
|
Chlordiazepoxide | 9 | 2001 | 42 | 0.460 |
Why?
|
Benzamides | 5 | 2010 | 1379 | 0.450 |
Why?
|
Animals | 131 | 2019 | 168757 | 0.440 |
Why?
|
Pyridines | 7 | 2010 | 2825 | 0.430 |
Why?
|
Veterinary Medicine | 1 | 2011 | 21 | 0.410 |
Why?
|
Drug Interactions | 14 | 2009 | 1460 | 0.390 |
Why?
|
Xanthines | 4 | 1997 | 121 | 0.380 |
Why?
|
Receptors, Opioid, kappa | 3 | 2009 | 144 | 0.380 |
Why?
|
Narcotic Antagonists | 5 | 2009 | 562 | 0.380 |
Why?
|
Dizocilpine Maleate | 2 | 2008 | 176 | 0.370 |
Why?
|
Methamphetamine | 1 | 2012 | 154 | 0.370 |
Why?
|
Adenosine | 7 | 1990 | 825 | 0.370 |
Why?
|
Naloxone | 4 | 2009 | 367 | 0.360 |
Why?
|
Benzimidazoles | 3 | 2010 | 850 | 0.350 |
Why?
|
Macaca mulatta | 9 | 2011 | 2375 | 0.350 |
Why?
|
Haplorhini | 11 | 2005 | 552 | 0.320 |
Why?
|
GABA Modulators | 5 | 2002 | 107 | 0.310 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2007 | 64 | 0.300 |
Why?
|
Quinolines | 1 | 2012 | 732 | 0.300 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 4 | 2000 | 54 | 0.290 |
Why?
|
Substance Abuse, Intravenous | 2 | 2009 | 525 | 0.290 |
Why?
|
Substance-Related Disorders | 6 | 2011 | 4258 | 0.280 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2006 | 146 | 0.270 |
Why?
|
Oxazines | 6 | 2010 | 298 | 0.270 |
Why?
|
Lisuride | 2 | 2003 | 3 | 0.260 |
Why?
|
Morphine | 7 | 2019 | 657 | 0.260 |
Why?
|
Receptors, GABA-A | 8 | 2005 | 627 | 0.260 |
Why?
|
Infusions, Intravenous | 2 | 2011 | 2274 | 0.260 |
Why?
|
Receptors, Opioid, delta | 2 | 2009 | 47 | 0.250 |
Why?
|
Neurotransmitter Uptake Inhibitors | 4 | 1995 | 37 | 0.250 |
Why?
|
Dopamine Agents | 3 | 2002 | 189 | 0.240 |
Why?
|
Benzazepines | 6 | 2007 | 326 | 0.240 |
Why?
|
GABA-A Receptor Agonists | 5 | 2005 | 84 | 0.240 |
Why?
|
Hydrocortisone | 4 | 2007 | 1826 | 0.240 |
Why?
|
Benzodiazepinones | 4 | 1992 | 51 | 0.240 |
Why?
|
Clonidine | 5 | 2007 | 164 | 0.240 |
Why?
|
Cebinae | 1 | 2003 | 1 | 0.230 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2004 | 174 | 0.230 |
Why?
|
Macaca fascicularis | 11 | 2015 | 915 | 0.230 |
Why?
|
Drug-Seeking Behavior | 2 | 2015 | 48 | 0.230 |
Why?
|
Saliva | 2 | 2007 | 809 | 0.220 |
Why?
|
Male | 100 | 2019 | 350118 | 0.210 |
Why?
|
Electroshock | 14 | 1991 | 122 | 0.210 |
Why?
|
Benzopyrans | 3 | 2010 | 64 | 0.210 |
Why?
|
Benzodiazepines | 7 | 2002 | 1101 | 0.210 |
Why?
|
Receptors, Drug | 6 | 1992 | 160 | 0.210 |
Why?
|
Putamen | 5 | 1994 | 291 | 0.210 |
Why?
|
Nicotine | 7 | 1983 | 681 | 0.210 |
Why?
|
Receptors, Purinergic | 5 | 1990 | 66 | 0.200 |
Why?
|
Food | 7 | 2003 | 771 | 0.200 |
Why?
|
Caudate Nucleus | 5 | 1994 | 393 | 0.200 |
Why?
|
Dopamine | 8 | 2009 | 1591 | 0.200 |
Why?
|
Rats, Wistar | 6 | 2015 | 1901 | 0.190 |
Why?
|
Flumazenil | 9 | 2002 | 84 | 0.180 |
Why?
|
Disease Models, Animal | 9 | 2015 | 18029 | 0.180 |
Why?
|
Amino Acids | 1 | 2006 | 1736 | 0.180 |
Why?
|
Drug Partial Agonism | 1 | 2019 | 24 | 0.180 |
Why?
|
Pituitary-Adrenal System | 1 | 2003 | 553 | 0.180 |
Why?
|
Cues | 4 | 2015 | 873 | 0.170 |
Why?
|
Fentanyl | 2 | 1999 | 410 | 0.170 |
Why?
|
Dibenzazepines | 3 | 1985 | 26 | 0.170 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2003 | 703 | 0.160 |
Why?
|
Flupenthixol | 3 | 2007 | 12 | 0.160 |
Why?
|
Long-Term Potentiation | 2 | 2010 | 293 | 0.160 |
Why?
|
Receptors, AMPA | 2 | 2015 | 331 | 0.160 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 4 | 2010 | 422 | 0.160 |
Why?
|
Specimen Handling | 1 | 2003 | 694 | 0.160 |
Why?
|
Caffeine | 6 | 1989 | 699 | 0.160 |
Why?
|
Lorazepam | 3 | 1988 | 145 | 0.160 |
Why?
|
Primates | 3 | 2008 | 545 | 0.160 |
Why?
|
Neuropeptides | 1 | 2004 | 942 | 0.160 |
Why?
|
Histamine H1 Antagonists | 2 | 1988 | 100 | 0.150 |
Why?
|
Psychomotor Performance | 4 | 2010 | 1901 | 0.140 |
Why?
|
Reaction Time | 7 | 2003 | 2097 | 0.140 |
Why?
|
Wakefulness | 1 | 2003 | 1245 | 0.140 |
Why?
|
Prazosin | 2 | 2007 | 96 | 0.140 |
Why?
|
Membrane Glycoproteins | 2 | 2004 | 3768 | 0.140 |
Why?
|
Carbolines | 4 | 2002 | 265 | 0.130 |
Why?
|
Carrier Proteins | 7 | 2004 | 5021 | 0.130 |
Why?
|
Motor Activity | 6 | 2006 | 2714 | 0.130 |
Why?
|
Quinpirole | 2 | 2007 | 33 | 0.130 |
Why?
|
Diazepam | 6 | 2000 | 205 | 0.130 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 1 | 2015 | 31 | 0.130 |
Why?
|
Analgesics, Opioid | 4 | 2019 | 3674 | 0.130 |
Why?
|
Stem Cell Transplantation | 2 | 2015 | 1620 | 0.130 |
Why?
|
Heroin Dependence | 2 | 2008 | 175 | 0.130 |
Why?
|
Dextroamphetamine | 5 | 1987 | 129 | 0.130 |
Why?
|
Social Environment | 2 | 1999 | 1023 | 0.130 |
Why?
|
Amphetamine | 2 | 2010 | 225 | 0.130 |
Why?
|
N-Methylaspartate | 1 | 1995 | 231 | 0.130 |
Why?
|
Rats | 13 | 2015 | 24260 | 0.120 |
Why?
|
Stress, Psychological | 2 | 2007 | 4245 | 0.120 |
Why?
|
Theophylline | 3 | 1989 | 132 | 0.120 |
Why?
|
Phenylisopropyladenosine | 4 | 1988 | 14 | 0.120 |
Why?
|
Eating | 1 | 2001 | 1536 | 0.120 |
Why?
|
Macaca | 2 | 2002 | 440 | 0.120 |
Why?
|
Nalbuphine | 2 | 2004 | 20 | 0.120 |
Why?
|
Phosphodiesterase Inhibitors | 2 | 1997 | 215 | 0.120 |
Why?
|
Alfentanil | 2 | 2004 | 27 | 0.120 |
Why?
|
Clozapine | 5 | 1986 | 498 | 0.120 |
Why?
|
Corticotropin-Releasing Hormone | 2 | 2007 | 369 | 0.120 |
Why?
|
Mecamylamine | 6 | 1983 | 29 | 0.120 |
Why?
|
Fluoxetine | 4 | 2015 | 749 | 0.110 |
Why?
|
Prefrontal Cortex | 3 | 2010 | 2147 | 0.110 |
Why?
|
Stimulation, Chemical | 3 | 2006 | 326 | 0.110 |
Why?
|
Mesencephalon | 1 | 2015 | 329 | 0.110 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2015 | 1736 | 0.110 |
Why?
|
1-Methyl-3-isobutylxanthine | 2 | 1989 | 102 | 0.110 |
Why?
|
Pyrazoles | 3 | 1988 | 1972 | 0.110 |
Why?
|
Cholecystokinin | 1 | 1992 | 114 | 0.110 |
Why?
|
Levodopa | 2 | 2009 | 219 | 0.100 |
Why?
|
Muscle Rigidity | 2 | 2003 | 35 | 0.100 |
Why?
|
Imidazolidines | 1 | 2011 | 39 | 0.100 |
Why?
|
Adenosine-5'-(N-ethylcarboxamide) | 5 | 1990 | 15 | 0.100 |
Why?
|
Indoles | 4 | 2015 | 1839 | 0.100 |
Why?
|
Animal Husbandry | 1 | 2011 | 66 | 0.100 |
Why?
|
Buprenorphine | 1 | 2019 | 640 | 0.100 |
Why?
|
Spiro Compounds | 1 | 2011 | 76 | 0.100 |
Why?
|
Drug Synergism | 3 | 2007 | 1792 | 0.100 |
Why?
|
Pentobarbital | 3 | 1985 | 155 | 0.100 |
Why?
|
Habituation, Psychophysiologic | 1 | 2011 | 154 | 0.100 |
Why?
|
Thiophenes | 2 | 2007 | 588 | 0.100 |
Why?
|
Parkinson Disease, Secondary | 3 | 1998 | 126 | 0.090 |
Why?
|
Benzofurans | 2 | 2009 | 140 | 0.090 |
Why?
|
Citalopram | 3 | 2009 | 403 | 0.090 |
Why?
|
Parkinson Disease | 2 | 2015 | 2775 | 0.090 |
Why?
|
Antimetabolites | 1 | 2010 | 125 | 0.090 |
Why?
|
Pain Measurement | 1 | 2019 | 3420 | 0.090 |
Why?
|
Haloperidol | 3 | 1988 | 397 | 0.090 |
Why?
|
Drug Administration Schedule | 3 | 2009 | 4933 | 0.090 |
Why?
|
Protein Phosphatase 1 | 1 | 2009 | 137 | 0.090 |
Why?
|
Protein Subunits | 2 | 2005 | 959 | 0.090 |
Why?
|
Cycloserine | 1 | 2010 | 113 | 0.090 |
Why?
|
Equipment Failure | 1 | 2011 | 578 | 0.080 |
Why?
|
Catheters, Indwelling | 1 | 2011 | 426 | 0.080 |
Why?
|
Glycine | 1 | 2012 | 671 | 0.080 |
Why?
|
Pyrrolidines | 2 | 2009 | 342 | 0.080 |
Why?
|
Punishment | 2 | 1980 | 98 | 0.080 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2009 | 163 | 0.080 |
Why?
|
Vocalization, Animal | 2 | 2010 | 87 | 0.080 |
Why?
|
Respiration | 2 | 1997 | 1653 | 0.080 |
Why?
|
Antiparkinson Agents | 1 | 2009 | 184 | 0.080 |
Why?
|
Secondary Prevention | 2 | 2006 | 1530 | 0.080 |
Why?
|
Membrane Transport Proteins | 2 | 2004 | 1028 | 0.080 |
Why?
|
Grooming | 1 | 2007 | 37 | 0.080 |
Why?
|
Drug Combinations | 3 | 2001 | 1959 | 0.080 |
Why?
|
Apomorphine | 1 | 2007 | 150 | 0.070 |
Why?
|
Oxazoles | 1 | 1988 | 189 | 0.070 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2007 | 87 | 0.070 |
Why?
|
Rodentia | 1 | 2008 | 261 | 0.070 |
Why?
|
Isoxazoles | 1 | 1988 | 216 | 0.070 |
Why?
|
Dendritic Spines | 1 | 2008 | 233 | 0.070 |
Why?
|
Recurrence | 4 | 2004 | 8340 | 0.070 |
Why?
|
Pluripotent Stem Cells | 1 | 2013 | 795 | 0.070 |
Why?
|
Parkinsonian Disorders | 1 | 2009 | 275 | 0.070 |
Why?
|
Vasodilator Agents | 1 | 1990 | 977 | 0.070 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2007 | 189 | 0.070 |
Why?
|
Convulsants | 1 | 1986 | 70 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1294 | 0.070 |
Why?
|
Serotonin | 2 | 2009 | 1017 | 0.070 |
Why?
|
Propranolol | 1 | 2007 | 502 | 0.070 |
Why?
|
Drug Administration Routes | 1 | 2005 | 153 | 0.070 |
Why?
|
Cardiovascular System | 2 | 1997 | 832 | 0.060 |
Why?
|
Binding, Competitive | 6 | 1996 | 1157 | 0.060 |
Why?
|
Vesicular Biogenic Amine Transport Proteins | 1 | 2004 | 9 | 0.060 |
Why?
|
Angiotensin II | 1 | 1988 | 881 | 0.060 |
Why?
|
Receptors, Biogenic Amine | 1 | 2004 | 2 | 0.060 |
Why?
|
Yohimbine | 1 | 2004 | 62 | 0.060 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2003 | 36 | 0.060 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2004 | 47 | 0.060 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 1 | 2004 | 66 | 0.060 |
Why?
|
Morphine Derivatives | 1 | 2003 | 44 | 0.060 |
Why?
|
Membrane Transport Modulators | 1 | 2003 | 24 | 0.060 |
Why?
|
Vasoconstrictor Agents | 1 | 2007 | 642 | 0.060 |
Why?
|
Equipment Design | 1 | 2011 | 3582 | 0.060 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2004 | 177 | 0.060 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2003 | 205 | 0.060 |
Why?
|
Neurons | 3 | 2013 | 9338 | 0.050 |
Why?
|
Tranquilizing Agents | 1 | 1983 | 59 | 0.050 |
Why?
|
Blood-Brain Barrier | 1 | 2009 | 1017 | 0.050 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 1 | 2003 | 87 | 0.050 |
Why?
|
Exploratory Behavior | 1 | 2004 | 270 | 0.050 |
Why?
|
Female | 19 | 2013 | 380194 | 0.050 |
Why?
|
Cebidae | 1 | 1982 | 21 | 0.050 |
Why?
|
Stereoisomerism | 5 | 1992 | 624 | 0.050 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2004 | 322 | 0.050 |
Why?
|
Azabicyclo Compounds | 3 | 1987 | 68 | 0.050 |
Why?
|
Piperidines | 1 | 2010 | 1602 | 0.050 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1988 | 1121 | 0.050 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2003 | 648 | 0.050 |
Why?
|
Muscle Contraction | 1 | 2006 | 1240 | 0.050 |
Why?
|
Symporters | 1 | 2004 | 362 | 0.050 |
Why?
|
Catalepsy | 1 | 2000 | 34 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2004 | 4462 | 0.050 |
Why?
|
Barbiturates | 1 | 2001 | 114 | 0.050 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 4 | 2009 | 96 | 0.050 |
Why?
|
Models, Economic | 1 | 2004 | 713 | 0.050 |
Why?
|
Ataxia | 1 | 2002 | 304 | 0.050 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 1999 | 24 | 0.050 |
Why?
|
Nucleus Accumbens | 1 | 2002 | 366 | 0.040 |
Why?
|
Propiophenones | 2 | 1989 | 30 | 0.040 |
Why?
|
Pyridazines | 3 | 2002 | 202 | 0.040 |
Why?
|
GABA Antagonists | 3 | 2005 | 128 | 0.040 |
Why?
|
Phenanthridines | 2 | 1996 | 51 | 0.040 |
Why?
|
Acetamides | 1 | 2000 | 249 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2004 | 1072 | 0.040 |
Why?
|
2-Chloroadenosine | 2 | 1988 | 11 | 0.040 |
Why?
|
Ethanol | 1 | 2005 | 1342 | 0.040 |
Why?
|
Oxycodone | 1 | 2019 | 153 | 0.040 |
Why?
|
Conditioning, Classical | 1 | 2000 | 366 | 0.040 |
Why?
|
Cyproheptadine | 2 | 1988 | 21 | 0.040 |
Why?
|
Structure-Activity Relationship | 4 | 2003 | 3129 | 0.040 |
Why?
|
Purinergic P1 Receptor Antagonists | 1 | 1997 | 45 | 0.040 |
Why?
|
Carbon Radioisotopes | 2 | 1998 | 577 | 0.040 |
Why?
|
Bupropion | 2 | 1989 | 303 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2002 | 1375 | 0.040 |
Why?
|
Tripelennamine | 2 | 1986 | 6 | 0.040 |
Why?
|
Brain | 8 | 2009 | 26385 | 0.040 |
Why?
|
Receptors, Purinergic P1 | 1 | 1997 | 109 | 0.040 |
Why?
|
Nordazepam | 2 | 1986 | 5 | 0.030 |
Why?
|
Anesthetics, Local | 2 | 2002 | 985 | 0.030 |
Why?
|
Reward | 1 | 2003 | 941 | 0.030 |
Why?
|
Diphenhydramine | 2 | 1986 | 63 | 0.030 |
Why?
|
Adrenergic Antagonists | 1 | 1995 | 24 | 0.030 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2015 | 70 | 0.030 |
Why?
|
Ethylamines | 1 | 2015 | 15 | 0.030 |
Why?
|
Ergolines | 1 | 1995 | 61 | 0.030 |
Why?
|
Adrenergic Agonists | 1 | 1995 | 58 | 0.030 |
Why?
|
Receptors, Adrenergic, alpha | 1 | 1995 | 149 | 0.030 |
Why?
|
Time Factors | 7 | 2009 | 40075 | 0.030 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 1997 | 235 | 0.030 |
Why?
|
Blood Pressure | 2 | 1988 | 8554 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2004 | 6365 | 0.030 |
Why?
|
Phenethylamines | 1 | 1995 | 96 | 0.030 |
Why?
|
Radioligand Assay | 2 | 1992 | 374 | 0.030 |
Why?
|
GABA-A Receptor Antagonists | 2 | 2005 | 62 | 0.030 |
Why?
|
Cyclic AMP | 1 | 1997 | 1472 | 0.030 |
Why?
|
Environment | 2 | 2015 | 1124 | 0.030 |
Why?
|
Devazepide | 1 | 1992 | 4 | 0.030 |
Why?
|
Receptors, Cholecystokinin | 1 | 1992 | 18 | 0.030 |
Why?
|
Hexamethonium Compounds | 2 | 1983 | 23 | 0.030 |
Why?
|
Pyrimidines | 2 | 2000 | 2942 | 0.030 |
Why?
|
Binding Sites | 3 | 1991 | 6114 | 0.030 |
Why?
|
Meglumine | 1 | 1992 | 149 | 0.030 |
Why?
|
Salicylamides | 1 | 1991 | 33 | 0.030 |
Why?
|
Columbidae | 3 | 1985 | 40 | 0.030 |
Why?
|
Chlorpromazine | 2 | 1983 | 111 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 1999 | 1162 | 0.030 |
Why?
|
Indans | 1 | 1992 | 96 | 0.020 |
Why?
|
Aminopyridines | 1 | 2015 | 542 | 0.020 |
Why?
|
Midazolam | 2 | 1999 | 270 | 0.020 |
Why?
|
Mitosis | 1 | 1996 | 1208 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2006 | 4931 | 0.020 |
Why?
|
Nortropanes | 1 | 1990 | 13 | 0.020 |
Why?
|
Mazindol | 1 | 1989 | 13 | 0.020 |
Why?
|
Nomifensine | 1 | 1989 | 15 | 0.020 |
Why?
|
Synaptic Transmission | 2 | 2009 | 1178 | 0.020 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2010 | 246 | 0.020 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2009 | 43 | 0.020 |
Why?
|
Biogenic Monoamines | 1 | 1989 | 50 | 0.020 |
Why?
|
Synapses | 2 | 2009 | 1728 | 0.020 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2010 | 377 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 2429 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 1989 | 552 | 0.020 |
Why?
|
Nerve Fibers | 1 | 1992 | 687 | 0.020 |
Why?
|
Desipramine | 1 | 1988 | 184 | 0.020 |
Why?
|
Tomography, Emission-Computed | 3 | 1998 | 1144 | 0.020 |
Why?
|
Extracellular Space | 1 | 2009 | 594 | 0.020 |
Why?
|
Locomotion | 1 | 2010 | 378 | 0.020 |
Why?
|
Isomerism | 1 | 1987 | 201 | 0.020 |
Why?
|
Chlorpheniramine | 1 | 1986 | 13 | 0.020 |
Why?
|
Phenylephrine | 1 | 1988 | 301 | 0.020 |
Why?
|
Pyramidal Cells | 1 | 2009 | 363 | 0.020 |
Why?
|
Sulfur Compounds | 1 | 1987 | 31 | 0.020 |
Why?
|
Promethazine | 1 | 1986 | 29 | 0.020 |
Why?
|
Cimetidine | 1 | 1986 | 78 | 0.020 |
Why?
|
Naphthyridines | 1 | 1987 | 118 | 0.020 |
Why?
|
Barbital | 1 | 1985 | 1 | 0.020 |
Why?
|
Cinanserin | 1 | 1985 | 1 | 0.020 |
Why?
|
Theobromine | 1 | 1985 | 15 | 0.020 |
Why?
|
Heart Rate | 2 | 1988 | 4091 | 0.020 |
Why?
|
Ligands | 2 | 2009 | 3282 | 0.020 |
Why?
|
Mutation | 1 | 2010 | 29786 | 0.020 |
Why?
|
Muscimol | 1 | 1985 | 69 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 1992 | 894 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2009 | 836 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2012 | 63114 | 0.020 |
Why?
|
Phenazocine | 1 | 1985 | 7 | 0.020 |
Why?
|
Loxapine | 1 | 1985 | 3 | 0.020 |
Why?
|
Methylphenidate | 1 | 1989 | 473 | 0.020 |
Why?
|
Buspirone | 1 | 1985 | 82 | 0.020 |
Why?
|
Humans | 12 | 2015 | 744343 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2010 | 14557 | 0.020 |
Why?
|
Signal Transduction | 1 | 2008 | 23403 | 0.020 |
Why?
|
Dibenzothiazepines | 1 | 1985 | 103 | 0.020 |
Why?
|
Avoidance Learning | 1 | 1986 | 233 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2009 | 895 | 0.020 |
Why?
|
Phosphorylation | 1 | 2015 | 8436 | 0.010 |
Why?
|
Biogenic Amines | 1 | 2003 | 50 | 0.010 |
Why?
|
Thioridazine | 1 | 1983 | 33 | 0.010 |
Why?
|
Flunitrazepam | 1 | 2002 | 20 | 0.010 |
Why?
|
Alprazolam | 1 | 2002 | 98 | 0.010 |
Why?
|
Premedication | 1 | 1983 | 258 | 0.010 |
Why?
|
Septum of Brain | 1 | 2002 | 18 | 0.010 |
Why?
|
Feeding Behavior | 2 | 1986 | 3188 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2010 | 21827 | 0.010 |
Why?
|
Microinjections | 1 | 2002 | 327 | 0.010 |
Why?
|
Models, Neurological | 1 | 2009 | 1774 | 0.010 |
Why?
|
Neostriatum | 1 | 2002 | 250 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1996 | 19229 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7799 | 0.010 |
Why?
|
Appetitive Behavior | 1 | 1979 | 37 | 0.010 |
Why?
|
Mice | 4 | 2010 | 81183 | 0.010 |
Why?
|
Autoradiography | 2 | 1991 | 745 | 0.010 |
Why?
|
Air Pressure | 1 | 1979 | 75 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2008 | 1422 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1981 | 1386 | 0.010 |
Why?
|
Cell Membrane | 1 | 2008 | 3748 | 0.010 |
Why?
|
Lactates | 1 | 1998 | 432 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2002 | 1169 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 1990 | 3057 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1985 | 2866 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11483 | 0.010 |
Why?
|
Social Behavior | 1 | 2002 | 1127 | 0.010 |
Why?
|
Steroids | 1 | 2000 | 930 | 0.010 |
Why?
|
Nerve Endings | 1 | 1994 | 109 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 1998 | 748 | 0.010 |
Why?
|
Sleep | 1 | 2010 | 4623 | 0.010 |
Why?
|
Central Nervous System Stimulants | 1 | 2002 | 1148 | 0.010 |
Why?
|
Corpus Striatum | 1 | 1998 | 1221 | 0.010 |
Why?
|
Choice Behavior | 1 | 1978 | 803 | 0.010 |
Why?
|
Tritium | 1 | 1991 | 745 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8301 | 0.010 |
Why?
|
Pharmaceutical Preparations | 1 | 1978 | 1071 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1998 | 3760 | 0.000 |
Why?
|
Tissue Distribution | 1 | 1991 | 2327 | 0.000 |
Why?
|
Models, Statistical | 1 | 2002 | 5102 | 0.000 |
Why?
|
Phencyclidine | 1 | 1985 | 61 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 35421 | 0.000 |
Why?
|
Kinetics | 1 | 1989 | 6473 | 0.000 |
Why?
|
Species Specificity | 1 | 1983 | 2478 | 0.000 |
Why?
|
Adult | 1 | 2013 | 214055 | 0.000 |
Why?
|
Synaptosomes | 1 | 1978 | 115 | 0.000 |
Why?
|
Dogs | 1 | 1983 | 3912 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1992 | 11366 | 0.000 |
Why?
|
Drinking | 1 | 1978 | 197 | 0.000 |
Why?
|
Smoking | 1 | 1983 | 8987 | 0.000 |
Why?
|